Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN19506752
ISRCTN19506752
Completed
未知

Better Contraceptive Choices for Marginalized Women: A Randomised Controlled Trial Comparing Immediate or Interval Insertion of Intrauterine Contraception after Second Trimester Abortion

niversity of British Columbia (Canada)0 sites716 target enrollmentJune 15, 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsContraceptive managementIntrauterine contraceptive devicesPregnancy and Childbirth

Overview

Phase
未知
Intervention
Not specified
Conditions
Contraceptive management
Sponsor
niversity of British Columbia (Canada)
Enrollment
716
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

2011 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/21672213 protocol 2016 Other publications in https://pubmed.ncbi.nlm.nih.gov/27406214/ (added 28/10/2022)

Registry
who.int
Start Date
June 15, 2010
End Date
April 6, 2015
Last Updated
3 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
niversity of British Columbia (Canada)

Eligibility Criteria

Inclusion Criteria

  • •This study will be offered to all women who present at the study sites meeting all of the following criteria:
  • •1\. Have completed informed consent for an abortion over 12 and under 24 weeks gestational age
  • •2\. Have chosen an IUC (either LNG\-IUS or CuT380\-IUD) for contraception post abortion
  • •3\. Are residents of British Columbia (BC) registered with the Medical Services Plan health care system
  • •4\. Are able to give informed consent
  • •5\. No age limits. Women ot girls of any age, fulfilling the above criteria will be eligibile

Exclusion Criteria

  • •1\. Any of the following contraindications to use of a LNG\-IUC or a CuT380\-IUC:
  • •1\.1\. Uterine cavity anomalies causing distortion of the endometrial canal including fibroids of \> 5 cm, excluding repaired Uterine septum
  • •1\.2\. Current untreated PID, Chlamydia, gonorrhea, cervicitis or lower genital tract infection
  • •1\.3\. Wilson?s Disease (if choosing a CuT380\-IUC)
  • •1\.4\. Undiagnosed abnormal uterine bleeding
  • •1\.5\. Known uterine or cervical malignancy or cervical dysplasia
  • •1\.6\. Known or suspected progestin\-dependent neoplasia, including breast cancer (if choosing a LNG\-IUC)
  • •1\.7\. Active liver disease or dysfunction (if choosing a LNG\-IUC)
  • •1\.8\. Actual benign or malignant liver tumours (if choosing a LNG\-IUC)
  • •1\.9\. Hypersensitivity to levonorgestrel or any of the other ingredients in the formulation or component of the container components of MIRENA (if choosing a LNG\-IUC)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Investigating improvements in access to family planning for women with disabilities; a study of a disability-inclusive intervention in Kaduna city, Nigeria
ISRCTN12671153ondon School of Hygiene & Tropical Medicine1,900
Completed
Not Applicable
ifestyle interventions to prevent diabetes in pregnant mothersGestational diabetes mellitusPregnancy and Childbirth
ISRCTN18467720niversity of Oxford1,870
Unknown
Not Applicable
Contraceptive Awareness and Reproductive EducationContraceptionSexually Transmitted DiseasesPregnancy
NCT01132950Memorial Hospital of Rhode Island400
Completed
Not Applicable
Addressing violence against pregnant women in antenatal care: testing an intervention in South AfricaPast 12-months intimate partner violence, defined as self-reported incidence one or more times of any physical or sexual act of partner abuseNot Applicable
ISRCTN35969343World Health Organization (Switzerland)500
Completed
Not Applicable
Randomized Controlled Trial of Adjunctive Social Media for More Effective Contraceptive CounselingContraception
NCT01994005New York Presbyterian Hospital144